FindTrial
Sign In

Diagnostic accuracy of serum anti-thyroglobulin antibodies in thyroglobulin-undetectable patients with differentiated thyroid carcinoma after successful ablation

Diagnostic accuracy of serum anti-thyroglobulin antibodies in thyroglobulin-undetectable patients with differentiated thyroid carcinoma after successful ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-07000001
Enrollment
Unknown
Registered
2007-03-07
Start date
2005-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid carcinoma

Interventions

Gold Standard:
Index test:

Sponsors

Department of Nuclear Medicine, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The DTC patients with TG- TGAb+ and successful ablation of thyroid remnant

Exclusion criteria

Exclusion criteria: The DTC patients with TG-detectable, TGAb-undetectable (TG+ TGAb-) or thyroid remnant

Design outcomes

Primary

MeasureTime frame
positive likelihood ratio;sensitivity;negative likelihood;accuracy of diagnosis;specificit;—

Secondary

MeasureTime frame
positve predictive value;negative predictive valu;—

Countries

China

Contacts

Public ContactAnren Kuang
kuanganren@263.net+86 028 85422696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026